Celentis

celentis.bio ↗ ·Valencia ·Pre-seed

Celentis, the commercial brand of Opticalsens S.L., is a Valencia-based biotech company that develops colorimetric and fluorescent optical sensors and molecular probes for rapid, in-situ detection of drugs and cellular biomarkers. Its products include tests that detect drugs used in drug-facilitated assault in drinks within seconds, as well as molecular sensors of cellular senescence for research and pharmaceutical use, with applications in health, food and agriculture, hygiene and pharma. The company was incorporated in January 2024 as the first joint spin-off of the Universitat de València and the Universitat Politècnica de València. It grew out of the inter-university IDM institute together with the technology transfer company TRL+, and both universities are shareholders. In 2025 it won third prize in the startup category of the Santander X awards.

Founded
2024
Founders
2
Total funds raised
—
Rounds
0
SectorsBiotech, Diagnostics, Chemical sensors, Life sciences tools Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

Margarita Parra
Co-founder, Scientific Partner
Ramón Martínez Máñez
Co-founder, Scientific Partner

Global models

No comparables on record yet.

In the same niche 50 others

Most funded firstSee all 51 in Diagnostics & precision medicine testing →

Investors

No investors found yet.

Funding rounds

No announced rounds on record.

News

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list